Khat use as risk factor for psychotic disorders: A cross-sectional and case-control study in Somalia

BMC Medicine

Volumn 3, Issue , 2005, Pages

  Odenwald, Michael ^a   Neuner, Frank ^a,b   Schauer, Maggie ^a   Elbert, Thomas ^a,b   Catani, Claudia ^a   Lingenfelder, Birke ^a   Hinkel, Harald ^c   Häfner, Heinz ^d   Rockstroh, Brigitte ^a,b  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b Center for Psychiatry Reichenau   (Germany)

^c University of Konstanz   (Germany)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHA EDULIS EXTRACT; ALKALOID; CATHINONE; PLANT EXTRACT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; EXPERIENCE; FEMALE; GENDER; HIGH RISK POPULATION; HUMAN; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POSITIVE AND NEGATIVE SYNDROME SCALE; PREVALENCE; PSYCHOSIS; QUANTITATIVE ANALYSIS; RISK FACTOR; SOMALIA; STUDENT T TEST; SUBSTANCE ABUSE; WAR; CATHA; EXERCISE; POSTTRAUMATIC STRESS DISORDER; SEX RATIO;

ADOLESCENT; ADULT; ALKALOIDS; CASE-CONTROL STUDIES; CATHA; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; PLANT EXTRACTS; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTROPIC DRUGS; RESTRAINT, PHYSICAL; RISK FACTORS; SEX DISTRIBUTION; SOMALIA; STRESS DISORDERS, TRAUMATIC;

EID: 27544513484     PISSN: 17417015     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-3-5     Document Type: Article

References (38)

1. Halbach H: Medical aspects of the chewing of khat leaves. Bull World Health Organ 1972, 47:21-9.
2. Gegax TT: Meet the khat-heads. Newsweek 2002, 140:35.
3. UNODC: World Drug Report 2004. Vienna: United Nations Office on Drugs and Crime; 2004.
4. Kalix P: Catha edulis, a plant that has amphetamine effects. Pharm World Sci 1996, 18:69-73.
5. Elmi AS: The chewing of khat in Somalia. J Ethnopharmacol 1983, 8:163-76.
6. Kennedy JG, Teague J, Fairbanks L: Qat use in North Yemen and the problem of addiction: a study in medical anthropology. Cult Med Psychiatry 1980, 4:311-44.
7. Szendrei K: The chemistry of khat. Bull Narc 1980, 32:5-35.
8. Kalix P: Pharmacological properties of the stimulant khat. Pharmacol Ther 1990, 48:397-416.
9. Nencini P, Ahmed AM: Khat consumption: a pharmacological review. Drug Alcohol Depend 1989, 23:19-29.
10. Zelger JL, Schorno HX, Carlini EA: Behavioural effects of cathinone, an amine obtained from Catha edulis Forsk.: comparisons with amphetamine, norpseudoephedrine, apomorphine and nomifensine. Bull Narc 1980, 32:67-81.
11. Woolverton WL, Johanson CE: Preference in rhesus monkeys given a choice between cocaine and d, 1-cathinone. J Exp Anal Behav 1984, 41:35-43.
12. Bell DS: The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 1973, 29:35-40.
13. Griffith JD, Cavanaugh J, Held J, Oates JA: Dextroamphetamine. Evaluation of psychomimetic properties in man. Arch Gen Psychiatry 1972, 26:97-100.
14. Robinson TE, Becker JB: Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986, 396:157-98.
15. Angrist B, Rotrosen J, Gershon S: Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology (Berl) 1980, 72:17-9.
16. Janowsky DS, Davis JM: Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. Arch Gen Psychiatry 1976, 33:304-8.
17. Pantelis C, Hindler CG, Taylor JC: Use and abuse of khat (Cathaedulis): a review of the distribution, pharmacology, side effects and a description of psychosis attributed to khat chewing. Psychol Med 1989, 19:657-68.
18. Yousef G, Huq Z, Lambert T: Khat chewing as a cause of psychosis. Br J Hosp Med 1995, 54:322-6.
19. Jager AD, Sireling L: Natural history of Khat psychosis. Aust N Z J Psychiatry 1994, 28:331-2.
20. Alem A, Shibre T: Khat induced psychosis and its medico-legal implication: a case report. Ethiop Med J 1997, 35:137-9.
21. Dhadphale M, Omolo OE: Psychiatric morbidity among khat chewers. East Afr Med J 1988, 65:355-9.
22. Bhui K, Abdi A, Abdi M, Pereira S, Dualeh M, Robertson D, Sathyamoorthy G, Ismail H: Traumatic events, migration characteristics and psychiatric symptoms among Somali refugees - preliminary communication. Soc Psychiatry Psychiatr Epidemiol 2003, 38:35-43.
23. Griffiths P, Gossop M, Wickenden S, Dunworth J, Harris K, Lloyd C: A transcultural pattern of drug use: qat (khat) in the UK. Br J Psychiatry 1997, 170:281-4.
24. Poole R, Brabbins C: Drug induced psychosis. Br J Psychiatry 1996, 168:135-8.
25. Phillips P, Johnson S: How does drug and alcohol misuse develop among people with psychotic illness? A literature review. Soc Psychiatry Psychiatr Epidemiol 2001, 36:269-76.
26. Sato M, Numachi Y, Hamamura T: Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992, 18:115-22.
27. Mueser KT, Drake RE, Wallach MA: Dual diagnosis: a review of etiological theories. Addict Behav 1998, 23:717-34.
28. World Health Organization: Composite International Diagnostic Interview (CIDI): Core version 2.1 Version 1.1. Geneva: World Health Organization; 1997.
29. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-76.
30. Kay SR: Positive and negative syndromes in schizophrenia : assessment and research. New York: Brunner/Mazel; 1991.
31. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A: Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992, 20:1-97.
32. Hambrecht M, Maurer K, Hafner H, Sartorius N: Transnational stability of gender differences in Schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders. Eur Arch Psychiatry Clin Neurosci 1992 242:6-12.
33. UNICEF: From perception to Reality. A study on child protection in Somalia. Nairobi: UNICEF Somalia; 2003.
34. BK Lipska, ND Halim, PN Segal, DR Weinberger: Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J Neurosci 2002, 22:2835-42.
35. Farrell M, Boys A, Bebbington P, Brugha T, Coid J, Jenkins R, Lewis G, Meltzer H, Marsden J, Singleton N, et al.: Psychosis and drug dependence: results from a national survey of prisoners. Psychiatry 2002, 181:393-8.
36. Buhler B, Hambrecht M, Loffler W, an der Heiden W, Hafner H: Precipitation and determination of the onset and course of schizophrenia by substance abuse - a retrospective and prospective study of 232 population-based first illness episodes Schizophr Res 2002, 54:243-51.
37. Yui K, Ikemoto S, Goto K, Nishijima K, Yoshino T, Ishiguro T: Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects: susceptibility to psychotic states and implications for relapse of schizophrenia. Pharmacopsychiatry 2002, 35:62-71.
38. Saraceno B, Barbui C: Poverty and mental illness. Can J Psychiatry 1997, 42:285-90.